Uber Sexual Assault MDL 3090: Two Bellwether Verdicts, One Ninth Circuit Question
The most consequential appellate question in plaintiff personal injury this week belongs to In re Uber Technologies, Inc., Passenger Sexual Assault Litigation, MDL No. 3090, pending before U.S. District Judge Charles Breyer in the Northern District of California. Two bellwether trials have closed with opposite dollar outcomes but identical liability findings: a February 2026 Arizona-plaintiff verdict of $8.5 million, and an April 2026 North Carolina-plaintiff verdict of $5,000. Uber is appealing both.
The financial gap between those verdicts is secondary to the legal architecture underlying them. Uber's appeal targets the trial court's holding that the company owes passengers a non-delegable duty of care, which means Uber cannot insulate itself from assault liability by classifying its drivers as independent contractors. If the Ninth Circuit affirms that holding, every rideshare and gig-economy transportation platform in the circuit faces direct exposure for driver conduct regardless of how it classifies its workforce.
Four additional bellwether trials remain in MDL 3090. The next two are calendared for September 14, 2026, in San Francisco. Plaintiff steering committees will spend the summer building damages packages on the assumption that the non-delegable duty survives appellate scrutiny. The $5,000 North Carolina outcome delivers a practical caution: liability findings do not guarantee substantial damages in front of individual juries. Firms carrying individual Uber assault cases should stress-test damages presentations against the inter-bellwether variance before the fall calendar opens.
Counsel managing cases in MDL 3090 should treat September 14, 2026 as a hard deadline for auditing damages models, particularly economic harm and non-economic pain presentations to lay juries in future bellwether panels.
Michigan $20.6 Million Affirmance: The Cost of a Silent Defense at Closing
On May 22, 2026, the Michigan Court of Appeals published an affirmance of a $20.6 million personal injury verdict, Law360 No. 2481116, on behalf of a plaintiff struck by a van while clearing snow from his driveway. The decision rests on a preservation rule that appears in appellate records across virtually every jurisdiction in the country.
Defense counsel argued post-verdict that plaintiff counsel's closing argument had been inflammatory. The appellate panel declined to reach the merits: defense trial counsel had not objected when the statements were made. The contemporaneous-objection requirement was dispositive, and the $20.6 million award stood.
The ruling carries practical weight for both plaintiff and defense practices. Plaintiff counsel who deliver forceful closing presentations need not worry about post-verdict attack when defense sits silent throughout. Defense counsel who intend to preserve closing-argument error must object at the moment the statement is made, not after the verdict returns. For any firm where appeal is a realistic post-verdict outcome, maintaining a real-time objection log during closing argument is now a documented operational necessity under this published appellate record.
The Michigan $20.6 million affirmance confirms that failure to object to plaintiff closing argument contemporaneously forfeits appellate review statewide, insulating aggressive plaintiff presentations from post-verdict challenge when defense counsel waits to act.
Oregon and Virginia Expand UIM Recovery for Multi-Vehicle Plaintiff Households
Two state developments this week raise the economic ceiling on underinsured motorist claims in opposite corners of the country, and both favor the plaintiff side of the docket.
In Rogers v. Farmers Insurance Company of Oregon, No. 432 (Or. Ct. App., May 20, 2026), the court held that UIM coverage follows the person, not the vehicle. The plaintiff held two Farmers policies, one on a Mazda and one on a Lexus, each carrying $100,000 in UIM limits. Farmers denied the second policy's UIM benefits under a policy exclusion. The Court of Appeals found that exclusion violated Oregon statutory minimum requirements and declared it unenforceable, making both $100,000 limits available to the plaintiff.
For Oregon plaintiff firms, the practice change is immediate. Multi-vehicle household ownership should appear as a standard intake field on every automobile file. Any client carrying separate policies on multiple vehicles may hold stacking rights that carriers have been denying under Rogers-style exclusions. Medical providers carrying lien balances in Oregon motor-vehicle files should re-evaluate coverage in cases that previously appeared under-insured: the additional $100,000 layer directly expands the pool from which provider liens are satisfied, and files worth re-opening now may be sitting in accounts-receivable without that designation.
Virginia added a structural shift through HB 107 (enrolled, 2026 session), which strips UIM insurers of subrogation rights against underinsured motorists unless the motorist unreasonably fails to cooperate in the lawsuit's defense. Before HB 107, Virginia UIM carriers could pursue the tortfeasor independently after paying the plaintiff, complicating settlement negotiations and reducing tortfeasors' incentive to cooperate. Eliminating that subrogation right removes a friction point that has consistently prolonged Virginia UIM resolutions and should accelerate structured multi-layer settlement timelines statewide.
Oregon plaintiff firms should immediately screen pending automobile files for multi-vehicle UIM stacking opportunities under Rogers v. Farmers, and Virginia counsel should revise demand templates to reflect the insurer's eliminated subrogation right under HB 107.
Daubert Deadlines Dominate Two Major Product Liability MDL Dockets
Expert admissibility is the controlling variable on the two largest ongoing product liability multi-district litigations in the federal system, and both have hard 2026 milestones that will determine whether their plaintiff dockets survive into trial.
In In re Acetaminophen-ASD/ADHD Products Liability Litigation, MDL No. 3043 (S.D.N.Y., Judge Denise Cote), the Second Circuit heard oral argument on November 17, 2025. Plaintiff lead counsel Ashley Keller of Keller Postman LLC argued that Judge Cote misapplied Daubert by excluding causation experts and substituting her own scientific conclusions for jury fact-finding. A decision is expected sometime in 2026. Reinstatement of the excluded experts would revive thousands of dismissed claims. Plaintiff steering committees have been building parallel state-court tracks in more admissibility-favorable jurisdictions as a hedge, but a Second Circuit reversal would significantly reduce the urgency of that dual-track effort.
The Paragard IUD MDL in the Northern District of Georgia presents a more compressed timeline. The first bellwether produced a Teva defense verdict. The second bellwether has been postponed to fall 2026. Daubert and dispositive motions are due October 6, 2026, making expert admissibility the controlling gateway to any plaintiff trial opportunity in this MDL cycle. Two consecutive defense outcomes would sharply compress whatever settlement leverage plaintiff counsel currently hold across the docket.
Medical providers who have treated Paragard plaintiffs and carry unreimbursed balances should build the October 6, 2026 Daubert deadline into accounts-receivable projections. Cases that survive expert scrutiny and reach trial carry materially different recovery profiles than those that do not. Billing strategy should account for that distinction well before case resolution, not at it.
The October 6, 2026 Paragard MDL Daubert deadline and the forthcoming Second Circuit ruling in MDL No. 3043 are the two calendar dates that will set the expert-admissibility ceiling for federal product liability plaintiff dockets through the end of this litigation cycle.
California Fee-Division Timing: Chong v. Mardirossian and the Referral Network Risk
A January 8, 2026 published decision from the California Court of Appeal, Second District, Division Five, Chong v. Mardirossian Akaragian LLP, Case No. B341157, drew a firm line on when written client consent to a fee-division arrangement must be obtained in PI referral relationships.
The court held that California Rule of Professional Conduct 1.5.1's written-consent requirement attaches at the moment attorneys enter the fee-sharing agreement, not at the time of settlement. A PI firm that accepts a referral and documents the fee split only at or near the settlement stage risks having the entire division declared unenforceable. The published opinion also addressed client ratification of an unauthorized settlement by former attorneys, holding that agency-law estoppel governs and can bind the client under specific factual circumstances that the panel analyzed at length.
For referral-dependent California PI firms, two practice-management changes follow directly. First, fee-division agreements require written client consent obtained before any substantive work begins under the referral arrangement. Second, any mid-case substitution-of-counsel situation requires an immediate audit of existing fee agreements to identify Chong exposure before the incoming firm proceeds on the file.
Medical providers listed in the LawyersTrend directory who co-manage billing across multiple plaintiff firms on a single case file face a specific downstream risk from Chong-style fee disputes. Where a substitution-of-counsel event triggers inter-attorney litigation over the fee division, lien resolution can be delayed indefinitely as settlement funds become subject to conflicting claims. Providers who receive substitution-of-counsel notices in active files should seek written billing confirmation from incoming counsel before the dispute matures into contested litigation. Whether California appellate courts will extend Chong's timing rule to informal referral arrangements that predate Rule 1.5.1's effective date remains an open question before the bar.
California PI firms must obtain written client consent to any fee-division arrangement at the time the referral agreement is formed, not at settlement, or the division is unenforceable under Chong v. Mardirossian Akaragian LLP, B341157.